Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk (DE:NOV)
XETRA:NOV
Novo Nordisk (NOV) Stock Forecast & Price Target
126 Followers
See the Price Targets and Ratings of:
NOV Analyst Ratings
Moderate Buy
8 Buy
4 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NOV Stock 12 Month Forecast
Average Price Target
€132.18
▲(9.12% Upside)
| Highest Price Target€160.69 | Average Price Target€132.18 | Lowest Price Target€77.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Kepler Capital
Reiterated
07/19/24
Goldman Sachs
Reiterated
07/19/24
Berenberg Bank
Reiterated
07/11/24
J.P. Morgan
Reiterated
07/11/24
Deutsche Numis
Reiterated
07/10/24
Jefferies
Reiterated
07/02/24
DNB Markets
Reiterated
06/27/24
Citi
Reiterated
06/17/24
Bank of America Securities
Reiterated
06/14/24
Stifel Nicolaus
€127.21→€129.22
Buy
€129.22
(6.68% Upside)
Reiterated
05/14/24
Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK965 at StifelStifel analyst Eric Le Berrigaud raised the price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO) to DKK965.00 (from DKK950.00) while maintaining a Buy rating.
Morgan Stanley
€124.53→€132.57
Buy
€132.57
(9.44% Upside)
Reiterated
04/15/24
Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK990 at Morgan StanleyMorgan Stanley analyst Mark Purcell raised the price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO) to DKK990.00 (from DKK930.00) while maintaining a Overweight rating.
TD Cowen
€123.86→€141.14
Buy
€141.14
(16.52% Upside)
Reiterated
03/11/24
Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,054 at TD CowenTD Cowen analyst Steve Scala raised the price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO) to DKK1,054.00 (from DKK925.00) while maintaining a Outperform rating.
Best Analysts Covering Novo Nordisk
Which Analyst Should I Follow If I Want to Buy DE:NOV and Sell After:
1 Month
xxx
Success Rate
31/47 ratings generated profit
Average Return
+2.67%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 65.96% of your transactions generating a profit, with an average return of +2.67% per trade.
3 Months
xxx
Success Rate
21/27 ratings generated profit
Average Return
+9.70%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +9.70% per trade.
1 Year
Success Rate
27/27 ratings generated profit
Average Return
+42.11%
reiterated a buy rating 3 months ago
Copying Emily Field's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +42.11% per trade.
2 Years
xxx
Success Rate
27/27 ratings generated profit
Average Return
+92.50%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +92.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
NOV Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
0
0
0
0
0
Buy
17
14
19
21
26
Hold
8
7
11
9
10
Sell
3
1
1
2
3
Strong Sell
0
0
0
0
0
total
28
22
31
32
39
Each month's total comprises the sum of three months' worth of ratings.
NOV Financial Forecast
NOV Stock Forecast FAQ
What is DE:NOV’s average 12-month price target, according to analysts?
Based on analyst ratings, Novo Nordisk’s 12-month average price target is €132.18.
What is DE:NOV’s upside potential, based on the analysts’ average price target?
Novo Nordisk has 9.12% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Novo Nordisk a Buy, Sell or Hold?
Novo Nordisk has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 4 hold ratings and 1 sell ratings.
What is Novo Nordisk’s share price target?
The average share price target for Novo Nordisk is €132.18. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €160.69 ,and the lowest forecast is €77.00. The average share price target represents 9.12% Increase from the current price of €121.13.
The highest analyst share price target is €160.69 ,and the lowest forecast is €77.00. The average share price target represents 9.12% Increase from the current price of €121.13.
What do analysts say about Novo Nordisk?
Novo Nordisk’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of Novo Nordisk?
To buy shares of DE:NOV, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.